NCT04482478View on ClinicalTrials.gov

Clinical Trial for the Evaluation of the Efficacy and Safety of EDL on Dyspepsia

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

September 30, 2024

Study Completion Date

December 30, 2025

Conditions
Functional Dyspepsia
Interventions
DIETARY_SUPPLEMENT

Extract of Dolichos lablab Linne (EDL)

Investigational product (EDL): once a day, 2 tablets orally intake (Extract of Dolichos lablab Linne 715 mg/day)

OTHER

Placebo oral tablet

Placebo: consumed in the same way as the investigational product

Trial Locations (1)

13620

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER